Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes.

Journal of internal medicine - 1 Mar 2011

Luotola K, Pietilä A, Zeller T, Moilanen L, Kähönen M, Nieminen M S, Kesäniemi Y A, Blankenberg S, Jula A, Perola M, Salomaa V

Abstract excerpt

OBJECTIVES: To examine whether interleukin-1 receptor antagonist (IL-1Ra) is a predictor for clinically incident diabetes in subjects with metabolic syndrome (MetS) and whether its predictive power is independent of C-reactive protein (CRP), an established marker of inflammation. We further examined whether genetic variants at the interleukin-1 (IL-1) locus would predict clinically incident diabetes. DESIGN: Two...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to C-Reactive Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Follow-Up Studies

Share to Interleukin-1

Share to Interleukin 1 Receptor Antagonist Protein

Share to Metabolic Syndrome

Share to Sex Factors

Source

Identifiers

PMID: 21205020
DOI: 10.1111/j.1365-2796.2010.02294.x

Genes

CRP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes.PMID 21205020Read ↗

Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits.Semantic proximity Read ↗

Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis.Semantic proximity Read ↗

Genetic variation of the interleukin-1 family and nongenetic factors determining the interleukin-1 receptor antagonist phenotypes.Semantic proximity Read ↗

Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians.Semantic proximity Read ↗

Variants of the interleukin-1 receptor antagonist gene are associated with fat mass in men.Semantic proximity Read ↗

Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus.Semantic proximity Read ↗

Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the north Indian population.Semantic proximity Read ↗

Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes.Semantic proximity Read ↗

Association of variation in the interleukin-1 gene family with diabetes and glucose homeostasis.Semantic proximity Read ↗

Apolipoprotein B and Interleukin 1 Receptor Antagonist: Reversing the Risk of Coronary Heart DiseaseSemantic proximity Read ↗

Genetic associations of IL1RN polymorphisms with metabolic syndrome in a Korean population.Semantic proximity Read ↗

Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.